For: | Akiyama S, Fukuda S, Steinberg JM, Suzuki H, Tsuchiya K. Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases. World J Gastroenterol 2022; 28(25): 2843-2853 [PMID: PMC9280738 DOI: 10.3748/wjg.v28.i25.2843] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i25/2843.htm |
Number | Citing Articles |
1 |
François Maillet, Yann Nguyen, Olivier Espitia, Laurent Perard, Carlo Salvarani, Etienne Rivière, Dieynaba Ndiaye, Cécile-Audrey Durel, Philippe Guilpain, Luc Mouthon, Anna Kernder, Javier Loricera, Pascal Cohen, Isabelle Melki, Claire de Moreuil, Nicolas Limal, Arsène Mékinian, Nathalie Costedoat-Chalumeau, Nathalie Morel, Jonathan Boutemy, Loïc Raffray, Jean-Sébastien Allain, Valérie Devauchelle, Isabelle Kone-Paut, Marc Fabre, Marie Durel, Antoine Dossier, Sébastien Abad, Marcella Visentini, Adrien Bigot, Halil Yildiz, Olivier Fain, Maxime Samson, Guillaume Gondran, Vered Abitbol, Benjamin Terrier. Association between large vessel vasculitis and inflammatory bowel disease: a case-control study. Rheumatology 2025; doi: 10.1093/rheumatology/keaf030
|
2 |
Tristan Kollecker, Markus Nistal, Volker Waltz, Florian Ehard, Mark Moellers, Felix Gundling. Takayasu – Arteriitis nach COVID-19-Infektion bei einer 26 Jahre alten Patientin mit Morbus Crohn. Zeitschrift für Gastroenterologie 2024; 62(07): 1042 doi: 10.1055/a-2187-9295
|
3 |
Jayakanthan Kabeerdoss, Sumita Danda, Priyanka Srivastava, Reena Kerkhale, T. Sathish Kumar, Ruchika Goel, Debashish Danda. A pilot study of childhood-onset Takayasu arteritis using whole exome sequencing suggests oligogenic inheritance involving classical complement, collagen, and autoinflammatory pathways. Clinical Rheumatology 2024; 43(8): 2607 doi: 10.1007/s10067-024-07017-z
|
4 |
Qianjie Xu, Xiaosheng Li, Yuliang Yuan, Guangzhong Liang, Zuhai Hu, Wei Zhang, Ying Wang, Haike Lei. Development and validation of a nomogram for predicting immune-mediated colitis in lung cancer patients treated with immune checkpoint inhibitors: a retrospective cohort study in China. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1510053
|